Pharmaceutical firm Lundbeck’s antidepressant vortioxetine, which is sold under brand names Trintellix and Brintellix, has demonstrated an advantage in a head-to-head study against desvenlafaxine, which Pfizer is marketing in the US as Pristiq, Lundbeck has announced in a press release.
The study investigated the efficacy of vortioxetine in patients with Major Depressive Disorder (MDD) who had a partial response to selective serotonin reuptake inhibitor (SSRI) treatment when compared to desvenlafaxine, the statement reports.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Strategic Procurement Manager, Direct Spend (Category Manager) 
Senior Project Manager (GMP - Life Science) 
2 Sales Representatives and Product Specialists 
Director for innovative pre-clinical testing unit 
Biostatistician 
Chemist for Incoming Materials in QC Department 
Clinical Trial Manager for development of in vitro diagnostics 
Senior Manager, Clinical Trial Budget 
(Senior) Drug Substance Specialist 
Clinical Project Manager 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Analytical Senior Scientist 
Production Director 
Client Talent Acquisition Specialist 
Nordic Medical Affairs Manager